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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S235identify the SNPs. The haplotype analyses (haplotype frequency esti-
mation and pair wise linkage disequilibrium between the SNPs) were
carried out using Haploview (www.broad.mit.edu/mpg/haploview/). All
statistical analysis was performed with the SPSS software package
(version 16.0 for windows; SPSS Chicago, IL).
Results: The variant genotype of ESR-a, CALM-1 and GDF-5 genes were
found to be present at relatively higher frequency in cases than in the
controls. Risk increased in cases that carried combination of variant
genotypes of ESR a (Btg-AA) and GDF-5 (TT); CALM-1 (ApeKI-TG) and
GDF-5 (TT); CALM-1(ApeKI-TG) and ESR a (Btg-AA) resulting in 4.00-
6.00 fold elevated risk to KOA. The haplotype C-G-G and T-G-G of ESR- a
gene reduced the risk to OA. In contrast the haplotype T-G-C containing
variant of all three polymorphism of CALM-1 genewas over represented
in the cases, increasing the risk to 3.5 fold (OR ¼ 3.49, 95% CI ¼ 1.67–
7.27, p ¼ 0.000). A signiﬁcant association of this variant genotype was
also found with clinical scores of KOA (VAS, WOMAC). Signiﬁcant
increased risk of TT than CC was found among moderate occupational
status, the risk of TT (OR¼ 2.07, 95% CI¼ 1.18-3.62, p¼ 0.01) was higher
than CC of GDF-5 (BsiE1) genotype among MIG living standard in cases
compared to controls. Likewise, ESR-a, Btg-I risk genotype also shows
signiﬁcant with moderate occupation (OR ¼ 2.34, 95% CI ¼ 1.26-4.33, p
¼ 0.007) and MIG living standard (OR ¼ 1.48 95% CI ¼ 1.01–2.19, p ¼
0.04). However, the risk of GT (OR¼ 3.15, 95% CI¼ 1.48–6.68, p¼ 0.003)
was signiﬁcantly higher than TT of ApeKI genotype among MIG living
standard in cases as compared to controls.
Conclusion: The results suggest that GDF-5, ESR-a and CALM-1 gene
polymorphism is associated with Knee OA and SNP-SNP interaction
inﬂuences the development of Knee OA. Likewise, association of these
SNP with clinical scores has again demonstrated that these genetic
markers could be effectively used for predicting development and
progression of osteoarthritis. Moderate occupation and MIG living
standard are higher prone to develop OA on the basis of GDF-5 and ESR-
a, Btg-I risk genotype. It may be hypothesized that the presence of
variant GDF-5 (BsiE1), ESR- a, Btg-I genotypes increases OA risk in
moderate occupation and MIG living standards in our population.
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THE MTDNA HAPLOGROUPS ASSOCIATE WITH DIFFERENT
METHYLATION PATTERNS IN ARTICULAR CHONDROCYTES
I. Perez-Rego y, J. Fernandez Tajes y, M. Fernandez Moreno y,
A. Soto-Hermida y, M.E. Vazquez-Mosquera y, E. Cortes-Pereira y,
M. Tamayo Novas z, A. Mosquera Rey z, N. Oreiro-Villar y,
C. Fernandez-Lopez y, J. Fernandez-García z, F.J. Blanco y. y INIBIC-Hosp.
Univ.rio A Coru~na. Rheumatology Div.. Genomics Group., A Coru~na,
Spain; z INIBIC-Hosp. Univ.rio A Coru~na. Genetics Dept.., A Coru~na, Spain
Purpose: To analyze the inﬂuence of the mitochondrial background on
the methylation patterns of articular chondrocytes
Methods: DNAmethylation proﬁling was performed using the Inﬁnium
HumanMethylation27 beadchip. Previously, cartilage isolated DNA from
41 cartilage samples (13 from haplogorup J, 20 from haplogroup H and 8
from haplogroups U) was bisulﬁte-modiﬁed using EZ DNA methylation
kit and hybridized according to the manufacturer’s instructions. DNA
methylation M-values were obtained and further compared between
haplogroups using ANOVA and adjusting for cofounder effects of age,
gender, disease status, and hospital origin. Post-hoc analysis was per-
formed for analysing haplogroup pairwise differences. Enrichment in
biological process and molecular function was tested by Gene set
enrichment analysis using a conditional hypergeometric test. All stat-
istical analyses were conducted in R software.
Results:ANOVAanalysis showeda total of1929CpGprobeswith ap-value
under 0.05 (Fig.1); post-hoc analysis of ANOVA allowed us to identify 560
signiﬁcant probes (adjusted p-value <0.05) between haplogroup H and
haplogroup J, 440 signiﬁcant CpGs for haplogroup H versus haplogroup U
comparison, and a total of 1084 signiﬁcant probes for the remaining
pairwise comparison (haplogroup J versus haplogroup U). Gene set
enrichment analysis showed a total of 38 biological processes and 3
molecular function processes signiﬁcantly altered. DNA damage response
(p-value 6.332061e-05), positive regulations of cell cycle process (p-value
2.491685e-06), RNA biosynthetic process (p-value 9.502843e-07) as well
as mitochondrial electron transport, NADH to ubiquinone (p-value
9.111800e-04) were enhanced in carriers of the mtDNA haplogroup J.
Conclusions: The genome-wide methylation analysis shows a distinct
epigenetic proﬁle in articular chondrocytes attending to their mito-
chondrial background. The role played by the mtDNA haplogroups onSpanish patients with OA could be mediated by this particular epi-
genetic proﬁle.
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VITAMIN D RECEPTOR GENE POLYMORPHISMS MODULATE THE
CLINICO-RADIOLOGICAL RESPONSE TO VITAMIN D
SUPPLEMENTATION IN KNEE OSTEOARTHRITIS
D. Sanghi y, R.N. Srivastava y, S. Raj z, A. Mishra y, S.M. Natu y,
S. Agarwal x. yKing George Med. Univ., Lucknow, India; zMS Ramaiah,
Med. Coll., Bangalore, India; x Sanjay Gandhi Post Graduate Inst. of Med.
Sci., Lucknow, India
Purpose: Osteoarthritis (OA) is one of the most frequent causes of pain,
loss of function and disability in the elderly. Knee OA is particularly
common in Indian patients and there is currently no therapy that can
slow its progression. A beneﬁcial effect of vitamin D supplementation
on symptomatic improvement in OA knee patients has recently been
reported. Vitamin D receptor (VDR) gene plays an important role in
regulation of bone mass and in human articular chondrocytes of carti-
lage. In view of the importance of the vitamin D in bone development
the abnormalities in the VDR gene are viewed as potential contributors
to OA. Therefore, this study was planned as a pilot study to ﬁnd out to
whether the clinico-radiological response to vitamin D was modulated
by VDR gene polymorphisms.
Methods: This randomized placebo-controlled trial recruited 103 KOA
cases as per American College of Rheumatology (ACR) guideline having
vitamin D insufﬁciency (25(OH)D  50 nmol/L). Enrolled cases were
randomly allocated in two groups to receive placebo (51) and vitamin D
(52). Primary outcome measures: pain and functional disability which
were recorded by knee speciﬁc WOMAC index and secondary outcome
measurewere radiological features (joint spacewidth and osteophytes).
The serum levels of vitamin D were assessed by a method Enzyme
Linked Immunosorbent Assay using IDS, UK kit. Detection of VDR
polymorphisms (Taq1 & Apa I) were done by PCR-RFLP technique.
25(OH)D levels, clinical and radiological features were recorded at
baseline and at one year follow up.
Results: At one year, in vitamin D supplemented group, TT genotype of
TaqI polymorphism showed the maximum increment in the level of
25(OH)D in comparison to Tt and tt genotype whereas in placebo group
it remained same. No such association was observed for ApaI poly-
morphism. In clinical features, pain and functional disability improved
in each genotype although least in tt genotype in vitamin D supple-
mented group whereas in placebo group it signiﬁcantly worsened in Tt
and tt genotype. Total WOMAC scores improved in each genotype of
vitamin D supplemented group and was signiﬁcant in case of Tt and TT
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in vitamin D group whereas in placebo group decreased Medial-JSW
and increased Osteophyte was observed in Tt and tt genotype in com-
parion to TT genotype of TaqI polymorphism. These changes were of
borderline signiﬁcance. No similar effect was observed for ApaI
polymorphism.
Conclusions: VDR gene polymorphism (TaqI) inﬂuences the clinico-
radiological response to vitamin D supplementation in Osteoarthritis
knee with insufﬁcient 25-OHD levels. If these results are conﬁrmed by
the larger studies, this would justify tailoring vitamin D supplementa-
tion using VDR genotyping in vitamin D insufﬁcient KOA patients.
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TOWARDS A MOLECULAR DESCRIPTION OF DISEASE; A SYSTEMS
BIOLOGY APPROACH IN OSTEOARTHRITIS
L. Labusca y, U. Greiser z, F. Zugun Eloae x, K. Mashayekhi k. yUniv. Hosp.
Saint Spiridon, Iasi, Romania; zNetwork of Excellence for Functional
Biomaterials NFB Galway Ireland, Galway, Ireland; xDept. of Molecular
Genetics and Immunology “Gr.T.Popa: Univ. of Med. and Pharmacy Iasi
Romania, Iasi, Romania; k SBIM Systems Bioinformatics and Modeling
GmbH, Frankfurt, Germany, Frankfurt, Germany
Purpose: Osteoarthritis represents an increasing threat worldwide,
affects people of all ages, inducing premature disability and economic
impairment. Bioinformatics, computational and systems biology are
used for deﬁning molecular proﬁle of diseases by integrating available
information. This approach requires knowledge about details as well as
overview about predictable interconnections. Bioinformatics is pro-
posed as a tool in organizing existent knowledge aiming introduction of
the discovery science principles in handling clinical and experimental
data. Computational biology is used to detect possible correlations and
links in molecular pathways and further pointed as one useful method
to design focused systematic research.
Methods: Genes and proteins involved in the process speciﬁc to Homo
sapiens have been extracted using data available in Gene Cards, Uniprot,
pubmed cited literature and gene ontology (GO) databases. Interactions
network analysis was build using Gene Regulatory Network (GRN) and
Gene Set Enrichment Analysis (GSEA) considering the following factors;
down and up regulation, co expression, predicted protein interaction,
Transcription Factor (TF) regulation. ChIP-seq data sets were aligned
usin to build version version hg19 of the human genome. Enhancers
were deﬁned as regions of ChIP-seq enrichment for H3K27ac in human
cells.
Results: Several sets of genes previously associated with chondrocyte
metabolism and inﬂamation were identiﬁed. Gene expression not
previously associated with OA have been identiﬁed. OA-associated SNPs
appear in super-enhancers of chondroprogenitor cells.
Conclusion: systems biology approach in disease characterization has
the potential in deﬁning the pathological mechanisms, in offering bio-
marker and therapeutical targets. Our approach is acontribution in this
respect towards a deﬁnition of osteoarthritis.
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IMPROVED PREDICTION OF KNEE OSTEOARTHRITIS PROGRESSION
BY GENETIC POLYMORPHISMS. ARTHROTEST STUDY RESULTS
F.J. Blanco y, I. M€oller z, Arthrotest Study Group, N. Bartolome x,
M. Artieda x, D. Tejedor x, A. Martínez x, E. Montell k, H. Martínez k,
M. Herrero k, J. Verges k. y INIBIC-Hosp. Univ.rio A Coru~na, A Coru~na,
Spain; z Inst. Poal de Reumatología, Barcelona, Spain; x Progenika
Biopharma, S.A., Bilbao, Spain; kBioiberica S.A., Barcelona, Spain
Purpose: Single Nucleotide Polymorphisms (SNPs) are inherited
genetic variations that can predispose or protect individuals against
clinical events. Osteoarthritis (OA) has a multifactorial etiology with a
strong genetic component. Genetic factors inﬂuence not only knee OA
onset, but also disease progression. The aim of this study was to develop
a genetic prognostic tool to predict radiologic progression towards
severe disease in primary knee OA (KOA) patients.
Methods: Cross-sectional, retrospective, multicentric, association study
with Spanish KOA patients. 595 patients from 31 sites were selected.
Inclusion criteria: Caucasian patients aged 40 years at the time of
diagnosis of primary KOA, for whom two anteroposterior X-rays were
available, one corresponding to the time of OA diagnosis with Kellgren–
Lawrence grade 2 or 3 and the other to the end of the follow-up period.Patients who progressed to KL score 4 or were referred for total knee
replacement in  8 years since the diagnosis were classiﬁed as pro-
gressors to severe disease. A unique expert viewer measured the radi-
ologic progression from all X-rays. A candidate gene study analyzing
774 SNPs was conducted. SNP genotyping was performed with Illumina
Golden gate technology or KASPar chemistry. Clinical variables of the
initial stages of the disease (gender, BMI, age at diagnosis, OA in the
contralateral knee and OA in other joints) were registered as potential
predictors. Univariate analysis was done to identify associations
between the baseline clinical variables or SNPs and KOA progression.
SNPs and clinical variables with an association of p < 0.05 were inclu-
ded on the multivariate analysis using forward logistic regression.
Results: 282 patients fulﬁlled DNA and X-ray quality control criteria
(220 in the exploratory cohort and 62 in the validation cohort). The
univariate association analysis showed that one of the clinical variables
and 23 SNPs were signiﬁcantly associated to KOA severe progression in
the exploratory cohort (p < 0.05). The predictive accuracy of the clinical
variable was limited, as indicated by the area under the ROC curve (AUC
¼ 0.66). When genetic variables were added to the clinical model (full
model) the prediction of KOA progression was improved and the AUC
increased to 0.82. Combining only genetic variables, a predictive model
with a good accuracy (AUC ¼ 0.78) was also obtained. The predictive
ability for KOA progression of the full model was conﬁrmed on the
validation cohort (two-sample Z-test p ¼ 0.190).
Conclusions: Genetic polymorphisms predict radiologic progression
more accurately than clinical variables. An accurate prognostic tool to
predict primary KOA progression has been developed, based on genetic
and clinical information from OA patients. This model could help
clinicians optimize patients’ preventive and therapeutic care, according
to their OA progression rate, and personalize disease management.
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FUNCTIONAL ANALYSIS OF THE OSTEOARTHRITIS SUSCEPTIBILITY
LOCUS MARKED BY THE POLYMORPHISM rs10492367
K. Johnson, L.N. Reynard, J. Loughlin. Newcastle Univ., Newcastle upon
Tyne, United Kingdom
Purpose: The arcOGEN genome-wide association study, published in
2012, reported that the rs10492367 G to T single nucleotide poly-
morphism (SNP) marks a region on chromosome 12p that is associated
with hip osteoarthritis (OA) in Europeans, with an odds ratio (OR) of
1.14 and a p-value of 1.48  108. rs10492367 is an intergenic SNP
located 59 kb downstream of kelch domain-containing protein 5
(KLHDC5) and 96 kb downstream of parathyroid hormone-like hor-
mone (PTHLH). While there is sparse published data for KLHDC5,
PTHLH has been widely studied, with its protein having a crucial role in
endochondral ossiﬁcation. As rs10492367 is not in high linkage dis-
equilibrium (LD) with any common non-synonymous transcript poly-
morphisms, it is unlikely that the OA association is due to a change in
the coding sequence of either of these two nearby genes. Instead,
rs10492367 could function as a cis-acting polymorphism, inﬂuencing
PTHLH or KLHDC5 gene transcription, resulting in allelic expression
imbalance (AEI). Furthermore, as rs10492367 resides in a region pre-
dicted to have enhancer activity based on the ENCODE dataset, identi-
ﬁcation of functional variants within this region that affect such activity
will prove vital in dissecting the OA signal. Thus, the aims of this study
are to assess whether rs10492367 marks AEI in either PTHLH or
KLHDC5, and to determine if any intergenic SNPs in high LD (0.8) with
rs10492367 are functionally active in regulating enhancer activity of
this OA associated region.
Methods: Cartilage was obtained from the hip or knee of OA patients
who had undergone elective total joint replacement, and from non-OA
patients who had undergone total joint replacement as a result of a
neck-of-femur fracture (NOF). Using quantitative real-time polymerase
chain reaction (qPCR), overall expression of PTHLH and KLHDC5 was
measured in cDNA synthesised from cartilage RNA and stratiﬁed by
rs10492367 genotype. Allelic expression imbalance analysis was per-
formed using pyrosequencing. Since rs10492367 is intergenic, the
transcript SNPs rs6253 in PTHLH and rs9029 in KLHDC5 were used as
markers to measure allelic imbalance in 29 and 21 heterozygous OA
patients, respectively. The data was stratiﬁed by rs10492367 genotype
to evaluate whether any allelic differences corresponded to the pres-
ence of either of the association SNP alleles. Eight SNPs were in an LD of
0.8 with the association SNP; thus, 18 pGL3 promoter vector con-
structs were generated, each of which contained one of the alleles from
